BloombergThe iShares Nasdaq Biotechnology ETF over 12 months
Stocks sold off on Thursday after a post-Fed rally on Wednesday.
But the Nasdaq still gained ground thanks to the biotech sector which gained about 2% on Thursday. In fact, biotech stocks have been on fire all year. They’re up about 15% year-to-date.Last month, Max Nisen at Quartz wrote that while everyone is focusing on […]
View photo.(Bloomberg)The iShares Nasdaq Biotechnology ETF over 12 monthsStocks sold off on Thursday after a post-Fed rally on Wednesday.
But the Nasdaq still gained ground thanks to the biotech sector which gained about 2% on Thursday. In fact, biotech stocks have been on fire all year. They’re up about 15% year-to-date.Last month, Max Nisen at Quartz wrote that while everyone is focusing […]
View gallery.Biotech stocks have been breaking to new highs all over the market. Here are just a few:Esperion Therapeutics broke to a new high last week and skyrocketed Tuesday.
Ampio Pharmaceuticals bolted higher last week and touched a new high Wednesday.
Jazz Pharmaceuticals just hit a new high Wednesday as well.
The list goes on and on. Whether it is Receptos, NewLink Genetics, Biogen […]
With a firm “no comment” Janet Yellen shied away from burstng the bubble in “extremely stretched” Biotech and Social Media stocks, but was forced to admit that “overall measures of equity valluations are on the high side.” Then, rather oddly, she notes that The Fed sees unusually low spreads in corporate bond markets… which is odd since they have actually […]
The Dow rose 140 last Monday, was down 330 on Tuesday, up 260 on Thursday, and down 250 on Friday (before a late-day save and finishing down 145). This morning, the Dow is up by nearly 100. There are numerous reasons for the loss of market memory, not the least of which are wild moves by global central bankers and […]
Biotech stocks have been on a tear lately, with the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) outrunning the S&P 500 about 45% to 10% over the past 10 months. And momentum still is on biotechs’ side, with 57% of the XBI’s components trading above their respective 50-day moving average. For perspective, the S&P 500 only boasts 41% on that front, and […]
View All3 Biotech Stocks That Could Pop in a HeartbeatBiotech stocks have been on a tear lately, with the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) outrunning the S&P 500 about 45% to 10% over the past 10 months.Click to Enlarge And momentum still is on biotechs’ side, with 57% of the XBI’s components trading above their respective 50-day moving average. For […]
Biotech Company Could Be on the Cusp of New Proenzyme Drug for the Treatment and Prevention of Certain Forms of Cancer
By iCELL News on March 12, 2015 · Sector
The Wealthy Biotech Trader, an Investment Newsletter focused on showing everyday Investors new opportunities in rapidly growing, little-known Biotech stocks, would like to announce some recent breakthroughs in the development of new […]
Annual health tech fests like the JPMorgan Health Care Conference, Biotech Showcase, and One Med Forum came and went this year in San Francisco. The star performers in this sector no doubt have a lot to brag about. They will also have a lot of explaining to do when the biotech and health care sectors eventually crash.The NASDAQ Biotechnology Index […]
Sellers woke up from the weekend and hit the market hard today with volume soaring along with the US Dollar. The Dow Jones Industrial average fell more than 300 points leading all indexes lower with the Russell 2000 holding up the best. Biotech stocks held up relatively well despite the selling in the broader market. Clearly many traders are worried […]
